stockrow
Friday 6 November 2026
Export KMTS’s income statement to Excel — free account
Kestra Medical Technologies, Ltd.
KMTS Healthcare Medical Instruments & Supplies
Kestra Medical Technologies, Ltd.’s revenue for fiscal 2026 (year ended April 2026) was $95.1 million, up 59.0% from fiscal 2025.
- Revenue
- +59.9%
- EPS
- −50.0%
- Free cash flow
- −17.8%
- Total debt
- +74.7%
Quarter to July 2026, against a year earlier
27.97
2.53
−8.30%
Follow KMTS
Alert me
Kestra Medical Technologies, Ltd. (KMTS) P/E ratio
Kestra Medical Technologies, Ltd. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jul 2026 | 0.0× | — |
| Apr 2026 | 0.0× | — |
| Jan 2026 | 0.0× | — |
| Oct 2025 | 0.0× | — |
| 5 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PLSE Pulse Biosciences, Inc compare | n/m |
| KMTS Kestra Medical Technologies, Ltd. | n/m |
| STAA STAAR Surgical Company compare | n/m |
| AZTA Azenta, Inc. compare | n/m |
| XRAY DENTSPLY SIRONA Inc. compare | n/m |
| STVN Stevanato Group S.p.A. compare | 22.4× |
| LMAT LeMaitre Vascular, Inc. compare | 29.7× |
| ATRC AtriCure, Inc. compare | 199× |
| WRBY Warby Parker Inc. compare | 434× |
| Medical Instruments & Supplies industry median | 30.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)